Search Results 1851-1860 of 16103 for ozempic

  1. Publications - James F. Meschia, M.D. - Mayo Clinic

    Salem AM, Mateti NR, Adedinsewo D, Demirer M, Youssef H, Anisetti B, Shourav MMI, Middlebrooks EH, Meschia JF, Brott TG, Lin MP.

  2. Butyrate Adjuvant Therapy for Type 1 Diabetes - Mayo Clinic

    About this study. This study will test the efficacy of BKR-017 (colon-targeted 500 mg butyrate tablets) on insulin sensitivity, glucose control and ...

  3. Afamitresgene autoleucel (intravenous route) - Mayo Clinic

    Afamitresgene autoleucel injection is an antineoplastic (cancer) medicine that is made from your own white blood cells, which have been modified to recognize ...

  4. A Study to Evaluate Molecular Mechanisms of Exercise Benefits in Insulin Resistant People - Mayo Clinic

    The aim of the study is to investigate the effects of a 3-month resistance exercise program (in people aged 50 to 75) on muscle mass, body composition, ...

  5. P1101 in Treating Patients With Myelofibrosis - Mayo Clinic

    About this study. The purpose of this study is to evaluate the effectiveness of P1101 (polyethyleneglycol [PEG]-proline-interferon alpha-2b) in treating ...

  6. A Study to Determine the Effectiveness of Early Intensive vs. Escalation Approach to Treat Relapsing/Remitting Multiple Sclerosis - Mayo Clinic

    About this study. The purpose of this study is to determine whether an EHT approach to DMT, defined as use of one of five monoclonal antibodies (alemtuzumab ...

  7. Mayo Clinic

    Ryan was a patient that I met in concert with Tim Hobday, M.D., one of our medical oncologists. He has a very rare tumor called an appendiceal neuroendocrine ...

  8. Extension Study of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON-OLE) - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  9. A Study to Assess the MEK Inhibitor Mirdametinib (PD-0325901) in Patients with Neurofibromatosis Type 1 Associated Plexiform Neurofibromas - Mayo Clinic

    The purpose of this study is to evaluate PD-0325901 in the treatment of symptomatic inoperable neurofibromatosis type-1 (NF1)-associated plexiform neurofibromas ...

  10. Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors - Mayo Clinic

    Cabozantinib S-malate is a chemotherapy drug known as a tyrosine kinase inhibitor, and it targets specific tyrosine kinase receptors, that when blocked, may ...